Revising our attitudes towards agonist medications and their diversion in a time of pandemic()

The COVID-19 pandemic led government regulators to relax prescribing rules for buprenorphine and methadone, the agonist medications that effectively treat opioid use disorder, allowing for take home supplies of up to 28 days. These changes prioritized the availability of these medications over conce...

Descripción completa

Detalles Bibliográficos
Autores principales: del Pozo, Brandon, Rich, Josiah D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505066/
https://www.ncbi.nlm.nih.gov/pubmed/33138924
http://dx.doi.org/10.1016/j.jsat.2020.108139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505066/
https://www.ncbi.nlm.nih.gov/pubmed/33138924
http://dx.doi.org/10.1016/j.jsat.2020.108139

Ejemplares similares